English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
oncnursingnews
9 小时
LBS-007 Receives FDA Fast Track Designation for Acute Myeloid Leukemia
The FDA has granted fast track designation to LBS-007 for the treatment of patients with acute myeloid leukemia.
16 小时
Aptose Signs CRADA with NCI to Develop Tuspetinib for AML and MDS in Newly Launched ...
Tuspetinib selected for a prestigious national clinical research program for ability to target broad spectrum of AML and MDS ...
The American Journal of Managed Care
3 天
New CPX-351 Data Underscore Complexity of Treating AML in Older Patients
Phase 2 data show about half of patients with high-risk or secondary acute myeloid leukemia achieved a complete response or ...
Targeted Oncology
6 天
FDA Grants Fast Track Designation to LBS-007 in AML
LBS-007, a novel targeted therapy, has received FDA fast track designation for the treatment of acute myeloid leukemia.
emjreviews.com
6 天
Home Time Benefits in Older Leukemia Patients’ Treatments
Read on to discover how time spent at home has shown to impact treatment decision-making in older adults with acute myeloid ...
17 小时
Priothera to Present Trial in Progress Poster for Mocravimod at 2024 American Society of ...
Mocravimod is being investigated in a global MO-TRANS Phase 3 study in patients with acute myeloid leukemia undergoing allogeneic hematopoietic ...
8 天
on MSN
Chromosomal chaos promotes therapy resistance in leukemia cells and opens up new treatment ...
Chromosomal instability plays a crucial role in the progression of cancer: it shapes the properties of tumor cells and drives ...
Fred Hutch
1 天
Fred Hutch at ASH: Plenary session on socioeconomic barriers to transplant, new leukemia ...
Meeting & Exposition of the American Society of Hematology (ASH) will take place in San Diego, Calif. and online Dec. 7-10. Improving access to life-saving therapies for blood disorders is the theme ...
Zacks.com on MSN
13 小时
SNTI Stock Skyrockets on Initial Data From Phase I Cancer Study
Senti Biosciences, Inc. SNTI announced positive initial data from a phase I study that evaluated its chimeric antigen ...
16 小时
Aptose Biosciences signs CRADA with NCI to develop tuspetinib for AML, MDS
Aptose Biosciences (APTO) announced that the National Cancer Institute, NCI, part of the National Institutes of Health, and Aptose Biosciences ...
Medpage Today on MSN
2 天
Myelofibrosis: Transformation to Leukemia
A subset of patients with myeloproliferative neoplasms (MPNs) -- clonal disorders of hematopoietic stem cells that include ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈